US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist

1.950
-0.020-1.02%

Close May 31 16:00 ET

1.960
+0.010+0.51%

Post 17:13 ET

78.11MMarket Cap-2119P/E (TTM)

Cognition Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-167.80%-7.24M

13.57%-16.02M

46.43%-5.46M

-103,925.00%-4.16M

31.01%-3.7M

9.47%-2.71M

-410.41%-18.53M

-10,183.17%-10.18M

99.80%-4K

-488.68%-5.36M

Net income from continuing operations

-48.27%-9.15M

-20.52%-25.79M

-57.10%-8.14M

-1.87%-6.75M

17.84%-4.73M

-60.81%-6.17M

-82.63%-21.4M

29.39%-5.18M

-113.02%-6.63M

-286.04%-5.75M

Operating gains losses

--195K

----

Depreciation and amortization

-3.33%58K

7.23%252K

10.00%66K

8.33%65K

3.39%61K

7.14%60K

152.69%235K

160.87%60K

145.83%59K

Other non cash items

----

--318K

---5K

--5K

--0

--318K

----

Change In working capital

-74.61%483K

613.89%4.85M

126.04%1.55M

-74.98%1.45M

89.93%-56K

1,018.84%1.9M

-133.18%-943K

-366.49%-5.96M

17,427.27%5.78M

-220.09%-556K

-Change in receivables

-79.64%420K

270.06%2.39M

131.21%357K

-38.82%755K

-56.49%-784K

307.34%2.06M

-26.21%-1.41M

-4.47%-1.14M

-11.35%1.23M

-111.39%-501K

-Change in prepaid assets

909.72%583K

242.24%1.85M

411.43%895K

120.77%205K

39.19%824K

93.35%-72K

-6,300.00%-1.3M

348.72%175K

-491.67%-987K

202.96%592K

-Change in payables and accrued expense

-402.67%-377K

425.77%2.44M

111.53%603K

-87.62%672K

403.18%1.24M

86.09%-75K

-121.81%-749K

-251.45%-5.23M

408.52%5.43M

-180.20%-409K

-Change in other current liabilities

27.78%-26K

-23.97%-150K

-24.24%-41K

-5.41%-39K

-9.68%-34K

-80.00%-36K

---121K

---33K

---37K

-112.25%-31K

-Change in other working capital

-631.82%-117K

-164.02%-1.69M

-197.03%-261K

-201.39%-146K

-528.99%-1.3M

-99.09%22K

425.95%2.64M

268.13%269K

-3.36%144K

---207K

Cash from discontinued investing activities

Operating cash flow

-167.80%-7.24M

13.57%-16.02M

46.43%-5.46M

-103,925.00%-4.16M

31.01%-3.7M

9.47%-2.71M

-410.41%-18.53M

-10,183.17%-10.18M

99.80%-4K

-488.68%-5.36M

Investing cash flow

Cash flow from continuing investing activities

14.04%-147K

-200.00%-30K

-152.17%-58K

-350.00%-18K

69.40%-41K

-533.33%-171K

62.96%-10K

-23K

-4K

Net PPE purchase and sale

--0

14.04%-147K

-200.00%-30K

-152.17%-58K

-350.00%-18K

69.40%-41K

-533.33%-171K

62.96%-10K

---23K

---4K

Cash from discontinued investing activities

Investing cash flow

--0

14.04%-147K

-200.00%-30K

-152.17%-58K

-350.00%-18K

69.40%-41K

-533.33%-171K

62.96%-10K

---23K

---4K

Financing cash flow

Cash flow from continuing financing activities

120,030.00%11.99M

-18.48%4.52M

-52.57%2.44M

-100.35%-3K

660.16%2.1M

89.01%-10K

-89.58%5.55M

-88.91%5.14M

190.43%869K

67.62%-374K

Net issuance payments of debt

14.01%-178K

41.91%-811K

12.68%-179K

46.38%-215K

46.97%-210K

47.46%-207K

-420.90%-1.4M

23.51%-205K

---401K

---396K

Net common stock issuance

6,131.98%12.28M

0.15%5.33M

-50.83%2.62M

--212K

--2.31M

--197K

-87.96%5.32M

--5.32M

--0

Proceeds from stock option exercised by employees

----

--0

----

421.94%1.62M

-91.05%23K

25,300.00%1.27M

-35.29%22K

Net other financing activities

---106K

----

Cash from discontinued financing activities

Financing cash flow

120,030.00%11.99M

-18.48%4.52M

-52.57%2.44M

-100.35%-3K

660.16%2.1M

89.01%-10K

-89.58%5.55M

-88.91%5.14M

190.43%869K

67.62%-374K

Net cash flow

Beginning cash position

-28.01%29.92M

-24.05%41.56M

-29.27%32.97M

-18.75%37.19M

-24.65%38.81M

-24.05%41.56M

954.56%54.72M

460.89%46.61M

305.05%45.77M

285.17%51.51M

Current changes in cash

272.31%4.75M

11.51%-11.64M

39.69%-3.05M

-601.43%-4.22M

71.77%-1.62M

14.22%-2.76M

-126.56%-13.16M

-110.88%-5.05M

127.96%842K

-177.72%-5.74M

Effect of exchange rate changes

--0

500.00%4K

--0

133.33%1K

66.67%-1K

300.00%4K

90.91%-1K

116.67%4K

-114.29%-3K

62.50%-3K

End cash Position

-10.66%34.67M

-28.01%29.92M

-29.27%32.97M

-18.75%37.19M

-24.65%38.81M

-24.05%41.56M

460.89%46.61M

305.05%45.77M

Free cash flow

-163.80%-7.24M

13.57%-16.17M

46.18%-5.49M

-15,525.93%-4.22M

30.72%-3.71M

12.04%-2.75M

-411.32%-18.7M

-13,875.68%-10.19M

98.68%-27K

-489.12%-5.36M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-167.80%-7.24M	13.57%-16.02M	46.43%-5.46M	-103,925.00%-4.16M	31.01%-3.7M	9.47%-2.71M	-410.41%-18.53M	-10,183.17%-10.18M	99.80%-4K	-488.68%-5.36M
Net income from continuing operations	-48.27%-9.15M	-20.52%-25.79M	-57.10%-8.14M	-1.87%-6.75M	17.84%-4.73M	-60.81%-6.17M	-82.63%-21.4M	29.39%-5.18M	-113.02%-6.63M	-286.04%-5.75M
Operating gains losses	--195K	----	----	----	----	----	----	----	----	----
Depreciation and amortization	-3.33%58K	7.23%252K	10.00%66K	8.33%65K	3.39%61K	7.14%60K	152.69%235K	160.87%60K	160.87%60K	145.83%59K
Other non cash items	----	--318K	---5K	--5K	--0	--318K	----	----	----	----
Change In working capital	-74.61%483K	613.89%4.85M	126.04%1.55M	-74.98%1.45M	89.93%-56K	1,018.84%1.9M	-133.18%-943K	-366.49%-5.96M	17,427.27%5.78M	-220.09%-556K
-Change in receivables	-79.64%420K	270.06%2.39M	131.21%357K	-38.82%755K	-56.49%-784K	307.34%2.06M	-26.21%-1.41M	-4.47%-1.14M	-11.35%1.23M	-111.39%-501K
-Change in prepaid assets	909.72%583K	242.24%1.85M	411.43%895K	120.77%205K	39.19%824K	93.35%-72K	-6,300.00%-1.3M	348.72%175K	-491.67%-987K	202.96%592K
-Change in payables and accrued expense	-402.67%-377K	425.77%2.44M	111.53%603K	-87.62%672K	403.18%1.24M	86.09%-75K	-121.81%-749K	-251.45%-5.23M	408.52%5.43M	-180.20%-409K
-Change in other current liabilities	27.78%-26K	-23.97%-150K	-24.24%-41K	-5.41%-39K	-9.68%-34K	-80.00%-36K	---121K	---33K	---37K	-112.25%-31K
-Change in other working capital	-631.82%-117K	-164.02%-1.69M	-197.03%-261K	-201.39%-146K	-528.99%-1.3M	-99.09%22K	425.95%2.64M	268.13%269K	-3.36%144K	---207K
Cash from discontinued investing activities
Operating cash flow	-167.80%-7.24M	13.57%-16.02M	46.43%-5.46M	-103,925.00%-4.16M	31.01%-3.7M	9.47%-2.71M	-410.41%-18.53M	-10,183.17%-10.18M	99.80%-4K	-488.68%-5.36M
Investing cash flow
Cash flow from continuing investing activities	0	14.04%-147K	-200.00%-30K	-152.17%-58K	-350.00%-18K	69.40%-41K	-533.33%-171K	62.96%-10K	-23K	-4K
Net PPE purchase and sale	--0	14.04%-147K	-200.00%-30K	-152.17%-58K	-350.00%-18K	69.40%-41K	-533.33%-171K	62.96%-10K	---23K	---4K
Cash from discontinued investing activities
Investing cash flow	--0	14.04%-147K	-200.00%-30K	-152.17%-58K	-350.00%-18K	69.40%-41K	-533.33%-171K	62.96%-10K	---23K	---4K
Financing cash flow
Cash flow from continuing financing activities	120,030.00%11.99M	-18.48%4.52M	-52.57%2.44M	-100.35%-3K	660.16%2.1M	89.01%-10K	-89.58%5.55M	-88.91%5.14M	190.43%869K	67.62%-374K
Net issuance payments of debt	14.01%-178K	41.91%-811K	12.68%-179K	46.38%-215K	46.97%-210K	47.46%-207K	-420.90%-1.4M	23.51%-205K	---401K	---396K
Net common stock issuance	6,131.98%12.28M	0.15%5.33M	-50.83%2.62M	--212K	--2.31M	--197K	-87.96%5.32M	--5.32M	--0	--0
Proceeds from stock option exercised by employees	----	--0	--0	--0	----	----	421.94%1.62M	-91.05%23K	25,300.00%1.27M	-35.29%22K
Net other financing activities	---106K	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	120,030.00%11.99M	-18.48%4.52M	-52.57%2.44M	-100.35%-3K	660.16%2.1M	89.01%-10K	-89.58%5.55M	-88.91%5.14M	190.43%869K	67.62%-374K
Net cash flow
Beginning cash position	-28.01%29.92M	-24.05%41.56M	-29.27%32.97M	-18.75%37.19M	-24.65%38.81M	-24.05%41.56M	954.56%54.72M	460.89%46.61M	305.05%45.77M	285.17%51.51M
Current changes in cash	272.31%4.75M	11.51%-11.64M	39.69%-3.05M	-601.43%-4.22M	71.77%-1.62M	14.22%-2.76M	-126.56%-13.16M	-110.88%-5.05M	127.96%842K	-177.72%-5.74M
Effect of exchange rate changes	--0	500.00%4K	--0	133.33%1K	66.67%-1K	300.00%4K	90.91%-1K	116.67%4K	-114.29%-3K	62.50%-3K
End cash Position	-10.66%34.67M	-28.01%29.92M	-28.01%29.92M	-29.27%32.97M	-18.75%37.19M	-24.65%38.81M	-24.05%41.56M	-24.05%41.56M	460.89%46.61M	305.05%45.77M
Free cash flow	-163.80%-7.24M	13.57%-16.17M	46.18%-5.49M	-15,525.93%-4.22M	30.72%-3.71M	12.04%-2.75M	-411.32%-18.7M	-13,875.68%-10.19M	98.68%-27K	-489.12%-5.36M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall